2-Acetylamino‰uorene (AAF) is a procarcinogen and its activation mechanisms have been investigated in detail. AAF was metabolized to 2-acetylamino-9-‰uorenone (AAF ＝O) and 2-acetylamino-9-‰uorenol by S9 mix. The mutagenicity of AAF＝O in the presence of S9 mix was equal in potency to that of AAF in Salmonella typhimurium TA1538, but the activation mechanism of AAF＝O was poorly reported. In this study, we investigated possible ultimate species derived from AAF＝O; N-hydroxy-2acetylamino-9-‰uorenone (N-OH-AAF＝O), N-acetoxy-2acetylamino-9-‰uorenone (N-OAc-AAF＝O), N-hydroxy-2amino-9-‰uorenone (N-OH-AF＝O), and N-acetoxy-2-tri‰uoroacetylamino-9-‰uorenone (N-OAc-TFAAF＝O), a model compound for N-acetoxy-2-amino-9-‰uorenone (N-OAc-AF＝O), were synthesized and their mutagenicity was examined in S. typhimurium TA1538. The activation mechanism in S. typhimurium TA1538 was also investigated. The compounds in order of decreasing mutagenicity are N-OAc-TFAAF＝OÀN-OH-AF＝OÀN-OAc-AAF＝OÀ N-OH-AAF＝O. AAF＝O is at least partially responsible for the mutagenicity of AAF, since a small amount of AAF is oxidized to AAF＝O in the presence of S9 mix. Furthermore we suggest that an ultimate active species of AAF＝ O in S. typhimurium is N-OAc-AF＝O, with the same activation manner as AAF.
Introduction
The metabolic activation of 2-amino‰uorene (AF) and 2-acetylamino‰uorene (AAF) has been investigated in detail (1) . Theˆrst step in the metabolic activation of AAF involves N-hydroxylation by cytochrome P450 (2) . Fig. 1 shows the pathway for the metabolic activation of AAF. N-Hydroxylation is a necessary step in the metabolic activation of AAF, followed by conversion of N-hydroxy-2-acetylamino‰uorene (N-OH-AAF) to Nacetoxy-2-amino‰uorene (N-OAc-AF) by N,O-acyltransferase. The ester contains an excellent leaving group, and readily produces a nitrenium ion. The electrophilic AF derivative reacts with nucleophilic centers in DNA bases to form DNA adducts (1) .
We elucidated that AAF was oxidized to 2acetylamino-9-‰uorenol (AAF-OH) and 2-acetylamino-9-‰uorenone (AAF＝O) by a chemical model for cytochrome P450 (3) . AAF-OH and AAF＝O were tested for carcinogenic activity in rat relative to AAF, and reported to be weakly active and active, respectively (4) . Furthermore, AAF＝O was identiˆed as one of metabolite of AAF, after incubation with rat liver microsomal enzymes, although it did not show mutagenicity in Salmonella typhimurium by itself (1) . In the present study, weˆrst conˆrmed production of AAF＝O by incubating AAF with S9 mix. Since AAF＝O showed mutagenicity in the presence of S9 mix, we studied its active form. We synthesized several speculative ultimate forms of AAF＝O, and examined their mutagenicity in S. typhimurium TA1538, without S9 mix.
Materials and Methods
Chemicals: All reagents and solvents were the best quality commercially available and were used without further puriˆcation unless otherwise noted.
Characterization of compounds synthesized: Melting points were measured in a Yanagimoto micro melting-point apparatus and were uncorrected. MS spectra were determined with a Shimadzu GCMSQP5050A spectrometer. The NMR spectra were determined by a JEOL JNM-GX270 instrument, using TMS as an internal standard (in NMR description, s＝ singlet, d＝doublet, t＝triplet, m＝multiplet and br＝ broad peak). IR spectra were recorded on a Nihon Bunkou V-560 spectrophotometer. TLC was performed on precoated Kieselgel 60F254 (Merck) plates, and spots were visualized by UV light.
Synthesis of compounds: 2-Acetylamino-9-‰uorenol (AAF-OH): AAF-OH was prepared from 2amino-9-‰uorenol (Sigma-Aldrich, St. Louis, MO, USA) by acetylation with acetic anhydride. TLC on sili- ca gel was developed with 10z methanol-dichloromethane; mp 248.0-249.09 C (249-2509 C) (5). 2-Acetylamino-9-‰uorenone (AAF＝O): AAF＝O was synthesized by acetylation of 2-amino-9-‰uorenone (Sigma-Aldrich, St. Louis, MO, USA) by acetylation with acetic anhydride and pyridine. TLC on silica gel was developed with 5z methanol-dichloromethane; mp 231.0-232.09 C (233-2369 C) (5) . To prevent oxidation of N-hydroxylamine, all procedures were performed in a nitrogen atmosphere. N-Hydroxy-2-amino-9-‰uorenone (N-OH-AF＝O): N-OH-AF＝O was prepared by hydrogenation of 2-nitro-9-‰uorenone as described (6). 2-Nitro-9-‰uorenone (225 mg) was dissolved in THF (25 mL) and DMF (10 mL). Five percent Pd-C (100 mg) was added to the reaction mixture, which was stirred vigorously and cooled on ice, and hydrazine hydrate (200 mL) in THF (5 mL) was dropped into the reaction mixture below 5 9 C. The reaction mixture was stirred for 40 min,ˆltered, dried over sodium sulfate, evaporated to dryness, and further dried under vacuum, and then 274 mg (yield 89z) of a red solid was obtained. IR (KBr) cm -1 : 3273 (NH and OH), 1701 (C＝O); EI-MS m/z: [M ＋ ] 211; mp 1309 C dec. N-Hydroxy-2acetylamino-9-‰uorenone (N-OH-AAF＝O): N-OH-AAF＝O was synthesized by acetylation of N-OH-AF＝ O with acetyl chloride. 2-Nitro-9-‰uorenone (225 mg) was dissolved in THF (25 mL) and DMF (10 mL). Five percent Pd-C (100 mg) was added to the reaction mixture, which was stirred vigorously and cooled on ice, and hydrazine hydrate (200 mL) in THF (5 mL) was dropped into the reaction mixture below 59 C. The reac-tion mixture was stirred for 40 min, and then was added triethylamine (0.3 mL), and acetyl chloride (1.5 mL) dissolved in THF (5 mL) at a rate such that the temperature did not rise above 109 C. The reaction mixture was then stirred for 30 min at room temperature,ˆltered, and then diethyl ether (30 mL) was added. The organic extracts was stirred vigorously with a saturated NaHCO3 solution for 30 min and extracted three times with 0.1 M NaOH (50 mL). The alkaline solution was washed with diethyl ether and acidiˆed with concentrated HCl below pH 3. The precipitate wasˆltered, washed with water and dried under vacuum. One hundred sixtyve mg (yield 65z) of a yellow solid was obtained, and after recrystallization from ethanol, 139 mg (yield 55z) of yellow needles was obtained. TLC on silica gel was developed with 5z methanol-dichloromethane (silica gel). IR (KBr) cm -1 : 3449 (OH), 1703 (C＝O), 1641 (C ＝O); 1 H-NMR (270 MHz, CD3Cl, d): 2.22 (3H, s), 7.60-7.65 (4H, m), 7.70-7.80 (3H, m); HRMS-EI m/z: 253.0714 (Calcd. 253.0739); mp 1499 C dec. N-Acetoxy-2-acetylamino-9-‰uorenone (N-OAc-AAF＝O): N-OAc-AAF＝O was prepared from N-OH-AAF＝O by acetylation with acetic anhydride. A solid of N-OH-AAF＝O, which was obtained from diethyl ether extracts, was redissolved in pyridine (7 mL) and acetic anhydride (7 mL) was dropped into this reaction mixture, and then stirred over 2 h at room temperature. The reaction mixture was poured into crushed ice,ˆltered, and obtained 139 mg (yield 80z) of a yellow solid. The solid was crystallized from ethanol and H2O, and 118 mg (yield 68z) of yellow needles was obtained. TLC on sili-ca gel was developed with dichloromethane: ethyl acetate (4:1). 1 N-OH-TFAAF＝O was prepared from N-OH-AF＝O by tri‰uoroacetylation. The diethyl ether extracts of N-OH-AF＝O was obtained as described above. 2-Nitro-9-‰uorenone (225 mg) was dissolved in THF (25 mL) and DMF (10 mL). Five percent Pd-C (100 mg) was added to the reaction mixture, which was stirred vigorously and cooled on ice, and hydrazine hydrate (200 mL) in THF (5 mL) was dropped into the reaction mixture below 59 C. The reaction mixture was stirred for 40 min,ˆltered, added diethyl ether (50 mL), and then washed two times with water, dried over sodium sulfate. The diethyl ether extract was added into tri‰uoroacetic anhydride (3 mL) on an ice bath, and then stirred for 1 h at room temperature under the nitrogen gas. The reaction mixture was washed with H2O (40 mL) and saturated NaHCO3 (40 mL). The organic extract was washed with H2O (40 mL) and extracted three times with 1z NaOH (30 mL). The combined alkaline extracts were acidiˆed with concentrated HCl to pH 2. An orange solid formed in the solution, and then wasˆltered to obtain 68 mg of a yellow solid. Fifty-two mg (yield 34z) of pure product was obtained by chromatography on silica gel eluted with ethyl acetate:dichloromethane (1:10). IR (KBr) cm Analysis of AAF metabolites: Fifty nmol of AAF in acetonitrile (20 mL) was incubated with 50 mL of S9 mix in 500 mL reaction mixture for 20 min at 379 C. To the reaction mixture added 500 mL of 2 M HCl to stop the reaction, and was extracted three times with ethyl acetate. The ethyl acetate layer was dried over anhy-drous sodium sulfate, and the solvent was evaporated to give a solid. The solid was reconstituted in acetonitrile (100 mL) for HPLC analysis. HPLC was performed on an LC-6A series from Shimadzu Co. (Kyoto, Japan). A Mightysil RP-18 GP column (5 mm particle, 3.0 mm i.d. ×250 mm; Kanto Chemical Co., Tokyo, Japan) was used at 409 C, with an isocratic eluent of acetonitrile-20 mM sodium phosphate buŠer (pH 7.4) (1:2) and a ‰ow rate of 0.5 mL/min. The retention times of AAF＝O and AAF-OH in the HPLC conditions were 7.4 and 16.3 min, respectively.
Recovery of AAF-OH and AAF＝O after incubation with S9 mix: A known amount of AAF-OH or AAF ＝O was incubated in the presence and absence of S9 mix and the reaction mixtures were analyzed as described above (analysis of AAF metabolites) to determine the recovery of AAF-OH or AAF＝O.
Mutation assay: The mutation assay was carried out according to the method reported by Maron and Ames (7) . The bacterial strain used was S. typhimurium TA1538, provided by Professor B. N. Ames, University of California, Berkeley. The S9 prepared from Sprague-Dawley (SDJ) male rat treated with phenobarbital and 5,6-benzo‰avone was purchased from Oriental Yeast Co. Ltd (Tokyo, Japan). AAF, AAF＝O and N-OH-AAF＝O were dissolved in 50 mL of distilled dimethyl sulfoxide and the assay was performed by the method of preincubation in the presence of S9 mix (8) . The mutation assay for N-OH-AAF＝O, N-OAc-AAF＝O, N-OH-AF＝O, N-OH-TFAAF＝O and N-OAc-TFAAF＝ O were performed without S9 mix. In the procedure, the S. typhimurium TA1538 (0.1 mL) and 0.1 M sodium phosphate buŠer (0.5 mL) were mixed in a test tube, and the unstable compound, N-OH-AF＝O, N-OH-TFAAF＝O and N-OAc-TFAAF＝O was added immediately after the compound was dissolved in distilled dimethyl sulfoxide (50 mL), incubated for 20 min at 379 C, and then top agar (2 mL) was added, and the mixture was poured onto minimal-glucose plates. The plates were incubated for 44 h at 379 C and then the colonies were counted. Duplicate plates were used for each dose, and the experiments were repeated at least twice.
Results
Identiˆcation of AAF oxidation products by S9 mix: The compounds oxidized at C-9 position of ‰uorene ring, AAF-OH and AAF＝O, were formed during incubation with S9 mix. AAF decreased in a timedependent manner in the presence of S9 mix ( Fig. 2A) . AAF＝O and AAF-OH were detected by HPLC at retention times of 7.4 and 16.3 min, respectively, with a photodiode array detector. These retention times and their UV spectra were identical to those of authentic samples. The amount of AAF-OH increased in a timedependent manner ( Fig. 2A) , and that of AAF＝O in- creased quickly and then decreased (Fig. 2B ). AAF-OH and AAF＝O were formed from AAF in the presence of S9 mix, at 37z and 0.14z, respectively, during 20 min incubation. By quantitative analysis, the recovery of AAF, AAF-OH and AAF＝O in S9 mix were 97, 97 and 84z, respectively.
Mutagenicity of AAF＝O in the presence of S9 mix: The mutagenicity of AAF＝O was compared with that of AAF in S. typhimurium TA1538 in the presence of S9 mix (Fig. 3) . The mutagenicity was equal to that of AAF.
Mutagenicity of AAF＝O derivatives: N-OH-AAF ＝O and N-OAc-AAF＝O were synthesized as possible ultimate metabolites of AAF＝O and assayed by the Ames test. The mutagenicity of N-OAc-AAF＝O was higher than that of N-OH-AAF＝O without S9 mix, However, the mutagenicity of N-OH-AAF＝O in-creased by addition of S9 mix, and higher than that of N-OAc-AAF＝O without S9 mix (Fig. 4) . Thus, it is considered that N-OH-AAF＝O and N-OAc-AAF＝O are not important active forms of AAF＝O. We speculated that AAF＝O was oxidized by cytochrome P450 to form a proximate carcinogen, N-OH-AAF＝O, and it was subsequently deacetylated by a microsomal enzyme 
Discussion
AAF-OH and AAF＝O were formed during AAF metabolism by S9 mix (Fig. 2) . We conˆrmed that the 9 position of the ‰uorene ring is an easily oxidizable site (9, 10) . The total amount of AAF＝O and AAF-OH was less than the amount of AAF consumed, indicating that AAF is also oxidized via another pathway, which forms 7-hydroxy-AAF and 1-hydroxy-AAF (9) . AAF＝O may also be oxidized to other compounds since the amount of AAF＝O decreased after its formation. AAF＝O was mutagenic in S. typhimurium TA1538 in the presence of S9 mix and the mutagenic activity was equal to that of AAF ( Fig. 3) . It is important to elucidate the activation mechanism of AAF＝O in the presence of S9 mix.
Since N-acetoxy-2-acetylamino‰uorene (N-OAc-AAF) has been used in many experiments as a masked compound of N-OH-AAF, we synthesized N-OH-AAF ＝O and N-OAc-AAF＝O and assayed for mutagenicity by the Ames test. The mutagenicity of N-OAc-AAF＝O without S9 mix was higher than that of N-OH-AAF＝O without S9 mix, but lower than that of N-OH-AAF＝O with S9 mix (Fig. 4 ). We concluded that N-OH-AAF＝ O and N-OAc-AAF＝O are not the active forms of AAF＝O.
We considered that AAF＝O is oxidized by cytochrome P450, forming the proximate carcinogen N-OH-AAF＝O, and then subsequently deacetylated to form N-OH-AF＝O. Furthermore, N-OH-AF＝O is acetylated to N-OAc-AF＝O. We synthesized N-OAc-TFAAF ＝O and N-OH-TFAAF＝O as model compounds for N-OAc-AF＝O (8) and N-OH-AF＝O, respectively, and compared their mutagenicity in S. typhimurium TA1538. The compounds in order of decreasing mutagenicity are N-OAc-TFAAF＝OÀN-OH-TFAAF＝ OÀN-OH-AF＝O ( Fig. 5 ). Schut et al. reported that the activation of N-OH-AAF by microsome or S9 mix was completely inhibited by paraoxon, an N,Oacetyltransferase inhibitor; the data indicate that deacetylation is the most important step in the mutagenic activation of N-OH-AAF (11, 12) . Although we did not examined eŠect of paraxon, we speculate that AAF＝O was activated to form N-OAc-AF＝O in the same way as AAF (Fig. 6) .
Using model compounds with activated structures, we can elucidate a possible new activation pathway of AAF.
